Translational Pancreatology. New Approaches in the Development of Novel Biomarkers as Screening Methodologies for Pancreatic Cancer
Autor: | Roxana Resnik, Maria I. Vaccaro |
---|---|
Rok vydání: | 2018 |
Předmět: |
Oncology
Screening texts medicine.medical_specialty CIENCIAS MÉDICAS Y DE LA SALUD business.industry purl.org/becyt/ford/3.1 [https] Bioquímica y Biología Molecular medicine.disease Medicina Básica Pancreatic Cancer Traslacional Pancreatic cancer Internal medicine medicine purl.org/becyt/ford/3 [https] business Biomarkers |
Zdroj: | CONICET Digital (CONICET) Consejo Nacional de Investigaciones Científicas y Técnicas instacron:CONICET |
ISSN: | 2517-7419 |
DOI: | 10.31021/jtgch.20181101 |
Popis: | Pancreatic Ductal Adenocarcinoma (PDAC) is one of the rare cancers for which no significant improvements in diagnosis and therapy have been made in the last 30 years. Despite considerable progress the median survival of most patients is 5 to 6 months. Currently, 80% of patients diagnosed with pancreatic adenocarcinoma present with locally invasive and/or metastatic disease, resulting in a poor 5-year survival of |
Databáze: | OpenAIRE |
Externí odkaz: |